Cargando…
Imaging metastatic bone disease from carcinoma of the prostate
Imaging bone metastases from prostate cancer presents several challenges. The lesions are usually sclerotic and appear late on the conventional X-ray. Bone scintigraphy is the mainstay of lesion detection, but is often not suitable for assessment of treatment response, particularly because of a ‘fla...
Autores principales: | Messiou, C, Cook, G, deSouza, N M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768452/ https://www.ncbi.nlm.nih.gov/pubmed/19789531 http://dx.doi.org/10.1038/sj.bjc.6605334 |
Ejemplares similares
-
Functional imaging: what evidence is there for its utility in clinical trials of targeted therapies?
por: Tunariu, N, et al.
Publicado: (2012) -
Surgical treatment of metastatic bone disease of the distal extremities
por: Sebghati, Jennifer, et al.
Publicado: (2021) -
Differential proteomic alterations between localised and metastatic prostate cancer
por: Taylor, B S, et al.
Publicado: (2006) -
Future of prostate imaging: Artificial intelligence in assessing prostatic magnetic resonance imaging
por: Chervenkov, Lyubomir, et al.
Publicado: (2023) -
Biomarkers: the next therapeutic hurdle in metastatic renal cell carcinoma
por: Sonpavde, G, et al.
Publicado: (2012)